Search

Your search keyword '"Morais-Almeida, Mario"' showing total 296 results

Search Constraints

Start Over You searched for: Author "Morais-Almeida, Mario" Remove constraint Author: "Morais-Almeida, Mario"
296 results on '"Morais-Almeida, Mario"'

Search Results

1. Time to ACT-UP: Update on precautionary allergen labelling (PAL)

2. Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024)

3. Allergic and hypersensitivity condition in the International Patients’ Summary (IPS) standard: The need of updates through the International Classification of Diseases (ICD)-11

4. MASK-air: An OECD (Organisation for Economic Co-operation and Development) Best Practice for Public Health on Integrated Care for Chronic Diseases

5. Poor Rhinitis and Asthma Control Is Associated With Decreased Health-Related Quality of Life and Utilities: A MASK-air Study

6. Pediatric asthma comorbidities: Global impact and unmet needs

7. Updated grading system for systemic allergic reactions: Joint Statement of the World Allergy Organization Anaphylaxis Committee and Allergen Immunotherapy Committee

9. Development and validation of an electronic daily control score for asthma (e-DASTHMA): a real-world direct patient data study

10. Cutoff Values of MASK-air Patient-Reported Outcome Measures

12. Academic Productivity of Young People With Allergic Rhinitis: A MASK-air Study

13. The Allergic Rhinitis and Its Impact on Asthma (ARIA) Approach of Value-Added Medicines: As-Needed Treatment in Allergic Rhinitis

16. WAO-ARIA consensus on chronic cough – Part III: Management strategies in primary and cough-specialty care. Updates inCOVID-19

17. WAO-ARIA consensus on chronic cough - Part II: Phenotypes and mechanisms of abnormal cough presentation — Updates inCOVID-19

18. WAO-ARIA consensus on chronic cough – Part 1: Role of TRP channels in neurogenic inflammation of cough neuronal pathways

19. MASK-air®: An OECD (Organisation for Economic Coordination and Development) Best Practice for Public Health on integrated care for chronic diseases.

22. Allergy and coronavirus disease (COVID-19) international survey: Real-life data from the allergy community during the pandemic

23. Relevance of individual bronchial symptoms for asthma diagnosis and control in patients with rhinitis:A MASK-air study

24. Medical devices in allergy practice

25. Impact of COVID-19 on Pediatric Asthma: Practice Adjustments and Disease Burden

27. Research Priorities in Pediatric Asthma: Results of a Global Survey of Multiple Stakeholder Groups by the Pediatric Asthma in Real Life (PeARL) Think Tank

28. COVID-19, asthma, and biological therapies: What we need to know

29. Acute asthma management during SARS-CoV2-pandemic 2020

31. A WAO — ARIA — GA2LEN consensus document on molecular-based allergy diagnosis (PAMD@): Update 2020

32. IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper

34. Mobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK study

36. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology

37. World Health Organization (WHO) guideline on the complementary feeding of infants and young children aged 6−23 months 2023: A multisociety response

38. Response to: Grummer‐Strawn LM, Lutter CK, Siegfried N, et al. Response to: World Health Organization (WHO) guideline on the complementary feeding of infants and young children aged 6–23 months 2023: A multisociety response. JPGN 2024

40. Patient‐centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA‐EAACI approach – ARIA‐EAACI Task Force Report

42. Improvement of daily allergy control by sublingual immunotherapy: A MASK ‐air® study

43. Digitally-enabled, patient-centred care in rhinitis and asthma multimorbidity: The ARIA-MASK-air approach.

44. Consistent trajectories of rhinitis control and treatment in 16,177 weeks : the MASK-air® longitudinal study

45. Patient-centered digital biomarkers for allergic respiratory diseases and asthma:The ARIA-EAACI approach – ARIA-EAACI Task Force Report

46. Patient‐centred digital biomarkers for allergic respiratory diseases and asthma: the ARIA‐EAACI approach

47. Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The MASK-air (R) longitudinal study

48. Digitally‐enabled, patient‐centred care in rhinitis and asthma multimorbidity: The ARIA‐MASK‐air ® approach

49. Development and validation of an electronic daily control score for asthma (e-DASTHMA):a real-world direct patient data study

50. MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis

Catalog

Books, media, physical & digital resources